✦ LIBER ✦

Consortium analysis of 7 candidate SNPs for ovarian cancer

✍ Scribed by Susan J. Ramus; Robert A. Vierkant; Sharon E. Johnatty; Malcolm C. Pike; David J. Van Den Berg; Anna H. Wu; Celeste Leigh Pearce; Usha Menon; Aleksandra Gentry-Maharaj; Simon A. Gayther; Richard A. DiCioccio; Valerie McGuire; Alice S. Whittemore; Honglin Song; Douglas F. Easton; Paul D.P. Pharoah; Montserrat Garcia-Closas; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Kathryn L. Terry; Daniel W. Cramer; Shelley S. Tworoger; Susan E. Hankinson; Andrew Berchuck; Patricia G. Moorman; Joellen M. Schildkraut; Julie M. Cunningham; Mark Liebow; Susanne Krüger Kjaer; Estrid Hogdall; Claus Hogdall; Jan Blaakaer; Roberta B. Ness; Kirsten B. Moysich; Robert P. Edwards; Michael E. Carney; Galina Lurie; Marc T. Goodman; Shan Wang-Gohrke; Silke Kropp; Jenny Chang-Claude; Penelope M. Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Ellen L. Goode

Publisher: John Wiley and Sons
Year: 2008
Tongue: French
Weight: 251 KB
Volume: 123
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.23448

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs), for which there is evidence from previous studies of an association with variation in ovarian cancer or breast cancer risks. The SNPs selected for analysis were F31I (rs2273535) in AURKA, N372H (rs144848) in BRCA2, rs2854344 in intron 17 of RB1, rs2811712 5′ flanking CDKN2A, rs523349 in the 3′ UTR of SRD5A2, D302H (rs1045485) in CASP8 and L10P (rs1982073) in TGFB1. Fourteen studies genotyped 4,624 invasive epithelial ovarian cancer cases and 8,113 controls of white non‐Hispanic origin. A marginally significant association was found for RB1 when all studies were included [ordinal odds ratio (OR) 0.88 (95% confidence interval (CI) 0.79–1.00) p = 0.041 and dominant OR 0.87 (95% CI 0.76–0.98) p = 0.025]; when the studies that originally suggested an association were excluded, the result was suggestive although no longer statistically significant (ordinal OR 0.92, 95% CI 0.79–1.06). This SNP has also been shown to have an association with decreased risk in breast cancer. There was a suggestion of an association for AURKA, when one study that caused significant study heterogeneity was excluded [ordinal OR 1.10 (95% CI 1.01–1.20) p = 0.027; dominant OR 1.12 (95% CI 1.01–1.24) p = 0.03]. The other 5 SNPs in BRCA2, CDKN2A, SRD5A2, CASP8 and TGFB1 showed no association with ovarian cancer risk; given the large sample size, these results can also be considered to be informative. These null results for SNPs identified from relatively large initial studies shows the importance of replicating associations by a consortium approach. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Inter-patient variation in efficacy of f

Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy

✍ John T. Lam; Anna Kanerva; Gerd J. Bauerschmitz; Koichi Takayama; Kaori Suzuki; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

## Abstract ## Background Gene therapy offers a new strategy for cancer treatment. Adenoviruses represent the most widely used gene therapy vector and feature an excellent safety record. Conditionally replicative adenoviruses (CRAds) effect solid tumor penetration and tumor selective oncolysis and

Vitamin D receptor rs2228570 polymorphis

Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: Pooled analysis in five studies within the Ovarian Cancer Association Consortium

✍ Galina Lurie; Lynne R. Wilkens; Pamela J. Thompson; Michael E. Carney; Rachel T. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 225 KB 👁 1 views

## Abstract The association of invasive ovarian carcinoma risk with the functional polymorphism rs2228570 (__aka__ rs10735810; __Fok__I polymorphism) in the vitamin D receptor (__VDR__) gene was examined in 1820 white non‐Hispanic cases and 3479 controls in a pooled analysis of five population‐base

Validation of the use of DNA pools and p

Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs

✍ Mette Gaustadnes; Torben F. Ørntoft; Jens Ledet Jensen; Niels Torring 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Communicated by Graham R. Taylor Colorectal cancer (CRC) is a multifactorial disease that involves both lifestyle and genetic factors. To identify single nucleotide polymorphisms (SNPs) associated with sporadic CRC, we used pooled DNA samples representing 230 cases with sporadic CRC and 540 con

Tissue array analysis of expression micr

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer

✍ Véronique Ouellet; Marie-Claude Guyot; Cécile Le Page; Abdelali Filali-Mouhim; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 368 KB 👁 2 views

## Abstract Molecular profiling is a powerful approach to identify potential clinical markers for diagnosis and prognosis as well as providing a better understanding of the biology of epithelial ovarian cancer. On the basis of the analysis of HuFL expression data, we have previously identified gene

Common alleles in candidate susceptibili

Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer

✍ Maria Notaridou; Lydia Quaye; Dimitra Dafou; Chris Jones; Honglin Song; Estrid H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 331 KB 👁 2 views

## Abstract Common germline genetic variation in the population is associated with susceptibility to epithelial ovarian cancer. Microcell‐mediated chromosome transfer and expression microarray analysis identified nine genes associated with functional suppression of tumorogenicity in ovarian cancer

Comprehensive analysis of 989 patients w

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

✍ German Consortium for Hereditary Breast; Ovarian Cancer 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 200 KB

## Abstract The main focus of this German‐wide multi‐center study was to establish a __BRCA1____/____2__ mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes __BRCA1__ and _